Evaluation of Dendritic Cell Products Generated for Human Therapy and Post-Treatment Immune Monitoring - - BioPharm International

ADVERTISEMENT

Evaluation of Dendritic Cell Products Generated for Human Therapy and Post-Treatment Immune Monitoring


BioPharm International
Volume 21, Issue 3

21. Nicolette C, Healey D, Tcherepanova I, et al. Dendritic cells for active immunotherapy: Optimizing design and manufacture in order to develop commercially and clinically viable products. Vaccine. 2007; In press.

22. Zhong H, Shurin MR, Han B. Optimizing dendritic cell-based immunotherapy for cancer. Expert Rev Vaccines. 2007;6(3):333–45.

23. Sorg RV, Ozcan Z, Brefort T, Fischer J et al. Clinical-scale generation of dendritic cells in a closed system. J Immunother (1997). 2003;26(4):374–83.

24. Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, et al. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol. 1998;28(10):3128–36.

25. Noorman F, Braat EA, Barrett-Bergshoeff M, Barbe E, van Leeuwen A, Lindeman J, et al. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol. 1997;61(1):63–72.

26. Butterfield L, Whiteside T. Development of a potency assay for human dendritic cells: IL-12p70 production. J Immunother. 2007; In press.

27. Tatsumi T, Huang J, Gooding WE, Gambotto A, et al. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive TC1-type immunity. Cancer Res. 2003;63(19):6378–86.

28. Wiltrout RH, Gregorio TA, Fenton RG, Longo DL et al. Cellular and molecular studies in the treatment of murine renal cancer. Semin Oncol. 1995;22(1):9–16.

29. Elias M, van Zanten J, Hospers G, Setroikromo A, de Jong M, de Leij L, et al. Closed system generation of dendritic cells from a single blood volume for clinical application in immunotheraphy. J Clin Apher. 2005;20:197–207.

30. Tuyaerts S, Noppe SM, Corthals J, Breckpot K, Heirman C, De Greef C, et al. Generation of large numbers of dendritic cells in a closed system using cell factories. J Immunol Methods. 2002;264(1-2):135–51.

31. Proudfoot O, Apostolopoulos V, Pietersz GA. Receptor-mediated delivery of antigens to dendritic cells: anticancer applications. Mol Pharm. 2007;4(1):58-72.

32. Whiteside TL, Stanson J, Shurin MR, Ferrone S. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol. 2004;173(3):1526–34.

33. Williams MA, Porter M, Horton M, Guo J, Roman J, Williams D, et al. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells. J Allergy Clin Immunol. 2007;119(2):488–97.

34. Grohmann U, Fallarino F, Bianchi R, Belladonna ML, et al. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. J Immunol. 2003;171:2581–87.

35. Shankar G, Fourrier MS, Grevenkamp MA, Lodge PA. Validation of the COSTIM bioassay for dendritic cell potency. J Pharm Biomed Anal. 2004;36(2):285–94.

36. Whiteside T. Immune monitoring of clinical trials with biotherapies. Adv Clin Chem. 2007; In press.

37. Newton PJ, Weller IV, Katz DR, Chain BM. Autologous apoptotic T cells interact with dendritic cells, but do not affect their surface phenotype or their ability to induce recall immune responses. Clin Exp Immunol. 2003;133(1):50–8.

38. Whiteside TL. Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol. 2006;16:3–15.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis and GSK Trade Assets
April 22, 2014
Lilly to Acquire Novartis Animal Health
April 22, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here